上海醫藥(02607.HK)原董事長周軍被查 上周末辭職
上海市紀律檢查委員會的官方微信公眾號「廉潔上海」昨傍晚(20日)6時55分公告,上海實業(集團)有限公司總裁周軍涉嫌嚴重違紀違法,目前正接受上海市紀委監委紀律審查和監察調查。
此時,距上海醫藥(02607.HK)(601607.SH)宣布周軍辭職不到12小時。
上海醫藥昨日早上8時01分發公告,指周軍因個人事務不能夠投入充足時間履行職務,已辭去公司董事長、非執行董事、董事會戰略委員會召集人及委員以及在公司及其附屬擔任的其他一切職務,自上周六(18日)起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.